MONTREAL, Sept. 21, 2011 /CNW Telbec/ - Sanofi-aventis Canada is proud
to be the national sponsor of People vs. Cancer, a speaking tour of
three Canadian universities featuring Stephen Lewis, former Canadian
Ambassador to the United Nations and United Nations Special Envoy for
HIV/AIDS in Africa. The speaking tour, an initiative of the Campaign to
Control Cancer (C2CC), will highlight the United Nation's September
19-20, 2011 high level meeting on the prevention and control of
noncommunicable diseases and address the moral imperative for Canadian
leadership. Tour details can be found at www.peoplevscancer.ca.
One in three Canadians will face a cancer diagnosis in their lifetime.
The C2CC estimates that cancer rates can be cut in half in one
generation simply by acting on and implementing what we know already in
areas like tobacco control, maintaining a healthy weight and diet,
regular physical activity, limiting alcohol consumption, avoiding
tanning beds and UV exposure, and screening at-risk and vulnerable
"Sanofi and People vs. Cancer share the same vision: people are the
priority of and solution to our healthcare challenges in Canada," said
Hugh O'Neill, speaker, event sponsor and President and CEO of
sanofi-aventis Canada. "Everyone has to put patients first and find
solutions that are focused on improved patient outcomes. Sanofi has
been calling for transformational change in Canada and is eager to be
part of the dialogue People vs. Cancer is creating between young
people, academics, NGOs, government, as well as healthcare
practitioners, institutions and companies."
Sanofi's support of the People vs. Cancer tour coincides with the
Canadian affiliate's unveiling of its corporate logo for use in
Canada. "The new logo reflects our company's mission: bringing hope to
patients and improving collaboration between policy makers,
researchers, healthcare providers and the public - like those brought
together by the Campaign to Control Cancer - through a tireless
commitment to improving the lives of people in Canada and around the
world," said Mark Lievonen, President of Sanofi Pasteur Limited.
The launch of the new logo in Canada follows the company's launch at a
global corporate level on May 6 and the US launch in early June.
The legal names of sanof-aventis Canada Inc., based in Laval, and Sanofi
Pasteur Limited, based in Toronto, will remain unchanged. The creative
elements of the logo will apply to both Sanofi and Sanofi Pasteur.
Sanofi, a global and diversified healthcare leader, discovers, develops
and distributes therapeutic solutions focused on patients' needs.
Sanofi has core strengths in the field of healthcare with seven growth
platforms: diabetes solutions, human vaccines, innovative drugs, rare
diseases, consumer healthcare, emerging markets and animal health.
Sanofi is represented in Canada by the pharmaceutical company
sanofi-aventis Canada Inc., based in Laval, Quebec, and by the vaccines
company Sanofi Pasteur Limited, based in Toronto, Ontario. Together
they employ more than 2,000 people across the country. With combined
R&D investments of $159.2 million in 2010, they are leaders in Canada's
biopharmaceutical sector, a critical knowledge-based industry that
generates jobs, business and opportunity throughout the country.
For further information:
Tel. 514 956-4188